Evidence map›Paper›PMID 41384125›Full record

ArticleFrontiers in medicine2025

Gastric mucosal change after the eradication of

Na Rae Lim, Woo Chul Chung

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Na Rae LimDepartment of Internal Medicine, The Catholic University of Korea, St. Vincent's Hospital, Suwon, Republic of Korea.
Woo Chul ChungDepartment of Internal Medicine, The Catholic University of Korea, St. Vincent's Hospital, Suwon, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Eradication of Materials and methods: This study was conducted from March 2010 to September 2022, and enrolled 1,789 consecutive patients who underwent endoscopic submucosal dissection for gastric mucosal dysplasia. Patients who underwent two or more procedures for simultaneous or metachronous gastric epithelial dysplasia as high-risk groups for gastric cancer, and were confirmed to have Results: In univariate analysis, diffuse atrophy, map-like redness, and patchy redness at antrum after Conclusion: Map-like redness and patchy redness are newly identified endoscopic risk factors for gastric cancer in patients treated for

Indexed as

endoscopic submucosal dissectioneradication therapygastric cancerHelicobacter pylorimetachronous gastric cancer

Identifiers

PMID41384125
PMCPMC12689955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.